Quintrio
Home

TRANSPORTATION SERVICES

Strata Critical Medical, Inc. Class A Common Stock

SRTA

Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.

Last trade $5.27
Day change -$0.15 (-2.77%)
Day range $5.06 – $5.65
Volume 517,408
Market cap $484M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$484.11M
Price / earnings
—
Price / book
1.75×
Price / sales
1.72×
EV / sales
1.6×
EV / EBITDA
137.01×

Profitability

Earnings per share
-$0.28
Return on assets
-7.54%
Return on equity
-8.98%
Dividend yield
0%

Liquidity and leverage

Debt / equity
0×
Current ratio
2.77×
Quick ratio
2.77×
Cash ratio
0.78×

Cash flow

Price / cash flow
45.15×
Price / free cash flow
600.64×
Free cash flow
$806K

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for SRTA, quarterly periods
Line itemQ3 FY2026 Sep 30, 2026Q2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025
Revenue$74.08M$72.51M$67.38M$66.79M$49.3M
Cost of revenue$57.26M$57.29M$53.27M$55.12M$38.64M
Gross profit$16.82M$15.22M$14.12M$11.67M$10.65M
Selling, general and administrative$15.14M$14M$15.61M$16.83M$15.91M
Research and development$0$0$0-$1.35M$0
Total operating expenses$20.65M$20.62M$17.09M$18.08M$16.28M
Operating income-$3.83M-$5.41M-$2.97M-$6.41M-$5.62M
Interest expense$146K$331K$473K$0$1.13M
Income before taxes-$7.62M-$10.52M$2.4M-$5.39M-$9.66M
Income taxes$0$0$0$0$0
Net income-$7.62M-$10.52M$2.15M-$8.83M$57.42M
Net income attributable to common shareholders-$7.62M-$10.52M$2.15M-$8.83M$57.42M
EBITDA$3.48M$3.11M$86K-$3.4M-$3.92M
Basic earnings per share-$0.09-$0.12$0.03-$0.10$0.70
Diluted earnings per share-$0.09-$0.12$0.03-$0.10$0.70

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Zacks Investment Research

BrightSpring Health Services, Inc. (BTSG) Q3 Earnings and Revenues Surpass Estimates

BrightSpring Health Services reported Q3 2026 earnings of $0.54 per share, beating consensus estimates of $0.49, with revenues of $4.21 billion exceeding expectations by 9.17%. The company has outperformed the market by 60.8% year-to-date compared to the S&P 500's 12.8% gain. However, the stock received a Zacks Rank #3 (Hold) rating, suggesting near-term performance in line with the market.

Zacks Investment Research

Alignment Healthcare (ALHC) Reports Q3 Loss, Beats Revenue Estimates

Alignment Healthcare (ALHC) reported a quarterly loss of $0.04 per share, matching consensus estimates, with revenues of $1.36 billion exceeding expectations by 3.63%. However, the stock has declined 58.6% year-to-date, significantly underperforming the S&P 500's 13.1% gain. The company received a Zacks Rank #4 (Sell) rating due to unfavorable estimate revision trends, with the Medical Services industry ranking in the bottom 40% of sectors.

GlobeNewswire Inc.

Strata Critical Medical Schedules Second Quarter 2026 Earnings Conference Call

Strata Critical Medical (Nasdaq: SRTA) announced it will release Q2 2026 financial results on August 4, 2026, followed by a conference call at 8:00 am ET hosted by Co-CEOs Melissa Tomkiel and Will Heyburn. The company is a time-critical logistics and medical services provider specializing in organ transplant services, air/ground logistics, and surgical recovery operations.

GlobeNewswire Inc.

Strata Critical Medical Schedules Fourth Quarter 2025 Earnings Conference Call

Strata Critical Medical (Nasdaq: SRTA) announced it will release fourth quarter 2025 financial results on March 3, 2026, followed by a conference call at 8:00 am ET hosted by Co-CEOs Will Heyburn and Melissa Tomkiel. The company is a time-critical logistics and medical services provider specializing in organ transplant networks and surgical services.

GlobeNewswire Inc.

Strata Critical Medical, Inc. Appoints Will Cook to Board of Directors

Strata Critical Medical has appointed Will Cook, President and CEO of Vail Health, to its Board of Directors. Cook brings extensive healthcare leadership experience from roles at University of Colorado Hospital, UPMC, and Johns Hopkins Health System.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily

No stock split records found.